← Evidence map

SynthesisEpidemiology and health2022

Quantifying the duration of the preclinical detectable phase in cancer screening: a systematic review.

Sandra M E Geurts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 34990529